skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Male remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Motzer, Robert ; Alekseev, Boris ; Rha, Sun-Young ; Porta, Camillo ; Eto, Masatoshi ; Powles, Thomas ; Grünwald, Viktor ; Hutson, Thomas E ; Kopyltsov, Evgeny ; Méndez-Vidal, María J ; Kozlov, Vadim ; Alyasova, Anna ; Hong, Sung-Hoo ; Kapoor, Anil ; Alonso Gordoa, Teresa ; Merchan, Jaime R ; Winquist, Eric ; Maroto, Pablo ; Goh, Jeffrey C ; Kim, Miso ; Gurney, Howard ; Patel, Vijay ; Peer, Avivit ; Procopio, Giuseppe ; Takagi, Toshio ; Melichar, Bohuslav ; Rolland, Frederic ; De Giorgi, Ugo ; Wong, Shirley ; Bedke, Jens ; Schmidinger, Manuela ; Dutcus, Corina E ; Smith, Alan D ; Dutta, Lea ; Mody, Kalgi ; Perini, Rodolfo F ; Xing, Dongyuan ; Choueiri, Toni K

The New England journal of medicine, 2021-04, Vol.384 (14), p.1289-1300 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
2
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer

Melisi, Davide ; Garcia-Carbonero, Rocio ; Macarulla, Teresa ; Pezet, Denis ; Deplanque, Gael ; Fuchs, Martin ; Trojan, Jorg ; Oettle, Helmut ; Kozloff, Mark ; Cleverly, Ann ; Smith, Claire ; Estrem, Shawn T ; Gueorguieva, Ivelina ; Lahn, Michael M F ; Blunt, Al ; Benhadji, Karim A ; Tabernero, Josep

British journal of cancer, 2018-11, Vol.119 (10), p.1208-1214 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study
Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study

Rosiñol, Laura ; Oriol, Albert ; Teruel, Ana Isabel ; Hernández, Dolores ; López-Jiménez, Javier ; de la Rubia, Javier ; Granell, Miquel ; Besalduch, Joan ; Palomera, Luis ; González, Yolanda ; Etxebeste, Mª Asunción ; Díaz-Mediavilla, Joaquín ; Hernández, Miguel T. ; de Arriba, Felipe ; Gutiérrez, Norma C. ; Martín-Ramos, Mª Luisa ; Cibeira, Mª Teresa ; Mateos, Mª Victoria ; Martínez, Joaquín ; Alegre, Adrián ; Lahuerta, Juan José ; San Miguel, Jesús ; Bladé, Joan

Blood, 2012-08, Vol.120 (8), p.1589-1596 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
4
A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma
A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma

Amengual, Jennifer E. ; Lichtenstein, Renee ; Lue, Jennifer ; Sawas, Ahmed ; Deng, Changchun ; Lichtenstein, Emily ; Khan, Karen ; Atkins, Laine ; Rada, Aishling ; Kim, Hye A. ; Chiuzan, Codruta ; Kalac, Matko ; Marchi, Enrica ; Falchi, Lorenzo ; Francescone, Mark A. ; Schwartz, Lawrence ; Cremers, Serge ; O'Connor, Owen A.

Blood, 2018-01, Vol.131 (4), p.397-407 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group
Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group

POPLIN, Elizabeth ; YANG FENG ; CELLA, David ; BENSON, Al Bowen ; BERLIN, Jordan ; ROTHENBERG, Mace L ; HOCHSTER, Howard ; MITCHELL, Edith ; ALBERTS, Steven ; O'DWYER, Peter ; HALLER, Daniel ; CATALANO, Paul

Journal of clinical oncology, 2009-08, Vol.27 (23), p.3778-3785 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma
Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma

Barnard, Rebecca A ; Wittenburg, Luke A ; Amaravadi, Ravi K ; Gustafson, Daniel L ; Thorburn, Andrew ; Thamm, Douglas H

Autophagy, 2014-08, Vol.10 (8), p.1415-1425 [Periódico revisado por pares]

United States: Taylor & Francis

Texto completo disponível

Citações Citado por
7
A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors
A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors

Soliman, Hatem H ; Jackson, Erica ; Neuger, Tony ; Dees, E Claire ; Harvey, R Donald ; Han, Hyo ; Ismail-Khan, Roohi ; Minton, Susan ; Vahanian, Nicholas N ; Link, Charles ; Sullivan, Daniel M ; Antonia, Scott

Oncotarget, 2014-09, Vol.5 (18), p.8136-8146

United States: Impact Journals LLC

Texto completo disponível

Citações Citado por
8
Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma
Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma

Tolcher, Anthony W. ; Patnaik, Amita ; Papadopoulos, Kyriakos P. ; Rasco, Drew W. ; Becerra, Carlos R. ; Allred, Alicia J. ; Orford, Keith ; Aktan, Gursel ; Ferron-Brady, Geraldine ; Ibrahim, Nageatte ; Gauvin, Jennifer ; Motwani, Monica ; Cornfeld, Mark

Cancer chemotherapy and pharmacology, 2015-01, Vol.75 (1), p.183-189 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
9
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

Venook, Alan P ; Niedzwiecki, Donna ; Lenz, Heinz-Josef ; Innocenti, Federico ; Fruth, Briant ; Meyerhardt, Jeffrey A ; Schrag, Deborah ; Greene, Claire ; O'Neil, Bert H ; Atkins, James Norman ; Berry, Scott ; Polite, Blase N ; O'Reilly, Eileen M ; Goldberg, Richard M ; Hochster, Howard S ; Schilsky, Richard L ; Bertagnolli, Monica M ; El-Khoueiry, Anthony B ; Watson, Peter ; Benson, Al B ; Mulkerin, Daniel L ; Mayer, Robert J ; Blanke, Charles

JAMA : the journal of the American Medical Association, 2017-06, Vol.317 (23), p.2392-2401 [Periódico revisado por pares]

United States: American Medical Association

Texto completo disponível

Citações Citado por
10
Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer

Hellmann, Matthew D ; Paz-Ares, Luis ; Bernabe Caro, Reyes ; Zurawski, Bogdan ; Kim, Sang-We ; Carcereny Costa, Enric ; Park, Keunchil ; Alexandru, Aurelia ; Lupinacci, Lorena ; de la Mora Jimenez, Emmanuel ; Sakai, Hiroshi ; Albert, Istvan ; Vergnenegre, Alain ; Peters, Solange ; Syrigos, Konstantinos ; Barlesi, Fabrice ; Reck, Martin ; Borghaei, Hossein ; Brahmer, Julie R ; O’Byrne, Kenneth J ; Geese, William J ; Bhagavatheeswaran, Prabhu ; Rabindran, Sridhar K ; Kasinathan, Ravi S ; Nathan, Faith E ; Ramalingam, Suresh S

The New England journal of medicine, 2019-11, Vol.381 (21), p.2020-2031 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (63.524)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (67.161)
  2. magazinearticle  (23)
  3. Anais de Congresso  (18)
  4. Web Resources  (1)
  5. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1982  (44)
  2. 1982Até1991  (3.687)
  3. 1992Até2001  (9.783)
  4. 2002Até2012  (25.624)
  5. Após 2012  (28.066)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (65.438)
  2. Japonês  (7.810)
  3. Alemão  (565)
  4. Francês  (390)
  5. Espanhol  (225)
  6. Chinês  (218)
  7. Russo  (185)
  8. Português  (82)
  9. Holandês  (58)
  10. Italiano  (50)
  11. Norueguês  (30)
  12. Polonês  (16)
  13. Hebraico  (15)
  14. Húngaro  (14)
  15. Tcheco  (14)
  16. Serbian  (12)
  17. Coreano  (12)
  18. Dinamarquês  (9)
  19. Ucraniano  (7)
  20. Romeno  (5)
  21. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.